NASDAQ:NDRA - ENDRA Life Sciences News Headlines

Sign in or create an account to add this stock to your watchlist.
$4.0799 -0.04 (-0.97 %)
(As of 11/13/2018 02:00 PM ET)
Previous Close$4.12
Today's Range$3.7652 - $4.27
52-Week Range$1.55 - $5.88
Volume259,882 shs
Average Volume950,769 shs
Market Capitalization$23.39 million
P/E RatioN/A
Dividend YieldN/A
Beta-4.12

Headlines

ENDRA Life Sciences (NASDAQ NDRA) News Headlines

Source:
DateHeadline
ENDRA Life Sciences Reports Third Quarter 2018 Financial ResultsENDRA Life Sciences Reports Third Quarter 2018 Financial Results
finance.yahoo.com - November 6 at 10:51 AM
My Stock of the Week: ENDRA Life SciencesMy Stock of the Week: ENDRA Life Sciences
finance.yahoo.com - October 29 at 3:33 PM
ENDRA Life Sciences (NDRA) Scheduled to Post Quarterly Earnings on MondayENDRA Life Sciences (NDRA) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - October 29 at 8:02 AM
ENDRA Life Sciences Inc (NDRA) Major Shareholder Longboard Capital Advisors, Ll Sells 130,200 SharesENDRA Life Sciences Inc (NDRA) Major Shareholder Longboard Capital Advisors, Ll Sells 130,200 Shares
www.americanbankingnews.com - October 25 at 4:16 PM
ENDRA Life Sciences (NDRA) vs. Nexeon Medsystems (NXNN) Critical ContrastENDRA Life Sciences (NDRA) vs. Nexeon Medsystems (NXNN) Critical Contrast
www.americanbankingnews.com - October 25 at 12:18 PM
ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at Three Global Liver and Imaging Conferences in November 2018ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at Three Global Liver and Imaging Conferences in November 2018
finance.yahoo.com - October 24 at 10:37 AM
ENDRA Life Sciences to Host Third Quarter 2018 Results Conference Call on Monday, November 5, 2018 at 4:30 p.m. ETENDRA Life Sciences to Host Third Quarter 2018 Results Conference Call on Monday, November 5, 2018 at 4:30 p.m. ET
finance.yahoo.com - October 23 at 10:28 AM
ENDRA Life Sciences Announces Closing of Public Offering and Exercise of Over-Allotment OptionENDRA Life Sciences Announces Closing of Public Offering and Exercise of Over-Allotment Option
finance.yahoo.com - October 16 at 10:18 AM
ENDRA Life Sciences Receives Approval to Initiate Human Studies of its TAEUS(TM) Device Targeting Non-Alcoholic Fatty Liver DiseaseENDRA Life Sciences Receives Approval to Initiate Human Studies of its TAEUS(TM) Device Targeting Non-Alcoholic Fatty Liver Disease
finance.yahoo.com - October 16 at 10:18 AM
The Daily Biotech Pulse: Clinical Hold Lifted Off Crisprs Gene-Edited Therapy, Endra To Offer SharesThe Daily Biotech Pulse: Clinical Hold Lifted Off Crispr's Gene-Edited Therapy, Endra To Offer Shares
www.benzinga.com - October 11 at 9:57 AM
ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the EASL Non-Alcoholic Fatty Liver Disease Summit in Geneva Switzerland on September 20-22, 2018ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the EASL Non-Alcoholic Fatty Liver Disease Summit in Geneva Switzerland on September 20-22, 2018
finance.yahoo.com - August 29 at 10:55 AM
Endra Life Sciences up 8%Endra Life Sciences up 8%
seekingalpha.com - August 17 at 3:29 PM
ENDRA Life Sciences Granted Two U.S. Patents For Correcting Fat-Induced Aberrations & Imaging Biological Tissue StructuresENDRA Life Sciences Granted Two U.S. Patents For Correcting Fat-Induced Aberrations & Imaging Biological Tissue Structures
finance.yahoo.com - July 31 at 10:46 AM
ENDRA Life Sciences to Host Second Quarter 2018 Results Conference Call on Monday, August 13, 2018 at 4:30 p.m. ETENDRA Life Sciences to Host Second Quarter 2018 Results Conference Call on Monday, August 13, 2018 at 4:30 p.m. ET
finance.yahoo.com - July 25 at 10:10 AM
ENDRA Life Sciences Granted U.S. Patent for Magnetic Resonance Imaging (MRI) Safety Based on TAEUS TechnologyENDRA Life Sciences Granted U.S. Patent for Magnetic Resonance Imaging (MRI) Safety Based on TAEUS Technology
finance.yahoo.com - July 12 at 10:15 AM
ENDRA Life Sciences Completes Private Placement of $1.1 Million of Convertible Secured Notes and WarrantsENDRA Life Sciences Completes Private Placement of $1.1 Million of Convertible Secured Notes and Warrants
finance.yahoo.com - July 2 at 2:13 PM
Your Daily Pharma Scoop: Endra Zooms, Biogen And Eisai Present Positive Results, Synergy Moves UpYour Daily Pharma Scoop: Endra Zooms, Biogen And Eisai Present Positive Results, Synergy Moves Up
seekingalpha.com - June 7 at 10:14 AM
ENDRA Life Sciences nabs U.S. patent assessing fat content in tissue, shares up 58.1%ENDRA Life Sciences nabs U.S. patent assessing fat content in tissue, shares up 58.1%
seekingalpha.com - June 5 at 3:27 PM
ENDRA Life Sciences Granted Third U.S. Patent for Non-Invasive Fat Assessment to Support TAEU(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver DiseaseENDRA Life Sciences Granted Third U.S. Patent for Non-Invasive Fat Assessment to Support TAEU(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease
finance.yahoo.com - June 5 at 10:12 AM
Should You Worry About ENDRA Life Sciences Inc’s (NASDAQ:NDRA) CEO Pay Check?Should You Worry About ENDRA Life Sciences Inc’s (NASDAQ:NDRA) CEO Pay Check?
finance.yahoo.com - May 25 at 10:24 AM
ENDRA Life Sciences (NDRA) CEO Francois Michelon on Q1 2018 Results - Earnings Call TranscriptENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 17 at 10:11 AM
ENDRA Life Sciences Reports First Quarter 2018 Financial ResultsENDRA Life Sciences Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 16 at 10:22 AM
ENDRA Life Sciences to Host First Quarter 2018 Results Conference Call on Tuesday, May 15, 2018 at 4:30 p.m. ETENDRA Life Sciences to Host First Quarter 2018 Results Conference Call on Tuesday, May 15, 2018 at 4:30 p.m. ET
finance.yahoo.com - April 26 at 9:52 AM
ENDRA Life Sciences to Showcase Photoacoustic Imaging Technology at American Association for Cancer Research (AACR) Annual Meeting on April 14-18 in ChicagoENDRA Life Sciences to Showcase Photoacoustic Imaging Technology at American Association for Cancer Research (AACR) Annual Meeting on April 14-18 in Chicago
finance.yahoo.com - April 9 at 9:18 AM
ENDRA Life Sciences to Present at The MicroCap Conference on Tuesday, April 10, 2018ENDRA Life Sciences to Present at The MicroCap Conference on Tuesday, April 10, 2018
finance.yahoo.com - April 2 at 3:24 PM
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2017 Financial ResultsENDRA Life Sciences Reports Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 21 at 8:30 AM
ENDRA Life Sciences Inc (NASDAQ:NDRA): Does The -48.17% Earnings Decline Make It An Underperformer?ENDRA Life Sciences Inc (NASDAQ:NDRA): Does The -48.17% Earnings Decline Make It An Underperformer?
finance.yahoo.com - March 8 at 3:28 PM
ENDRA Life Sciences to Host Fourth Quarter and Full Year 2017 Results Conference Call on Tuesday, March 20, 2018 at 4:30 p.m. ETENDRA Life Sciences to Host Fourth Quarter and Full Year 2017 Results Conference Call on Tuesday, March 20, 2018 at 4:30 p.m. ET
finance.yahoo.com - March 7 at 8:48 AM
ENDRA Life Sciences to Present at the Inaugural LD Micro Virtual Conference on Tuesday, March 6, 2018 at 5:00 p.m. ETENDRA Life Sciences to Present at the Inaugural LD Micro Virtual Conference on Tuesday, March 6, 2018 at 5:00 p.m. ET
finance.yahoo.com - February 27 at 3:28 PM
ENDRA Life Sciences Granted Two U.S. Patents for Non-Invasive Fat Assessment to Support TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver DiseaseENDRA Life Sciences Granted Two U.S. Patents for Non-Invasive Fat Assessment to Support TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease
finance.yahoo.com - February 15 at 9:47 AM
ENDRA Life Sciences Renews and Extends Term of Collaboration Agreement with GE Healthcare to Develop ENDRAs TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver DiseaseENDRA Life Sciences Renews and Extends Term of Collaboration Agreement with GE Healthcare to Develop ENDRA's TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease
finance.yahoo.com - February 5 at 5:23 PM
Who Are The Top Investors In ENDRA Life Sciences Inc (NASDAQ:NDRA)?Who Are The Top Investors In ENDRA Life Sciences Inc (NASDAQ:NDRA)?
finance.yahoo.com - December 28 at 5:18 PM
What Did ENDRA Life Sciences Inc’s (NDRA) CEO Take Home Last Year?What Did ENDRA Life Sciences Inc’s (NDRA) CEO Take Home Last Year?
finance.yahoo.com - December 9 at 8:50 AM
How ENDRA Life Sciences Inc’s (NDRA) EPS Dropped 45.2%, Did Its Industry Show Weakness Too?How ENDRA Life Sciences Inc’s (NDRA) EPS Dropped 45.2%, Did Its Industry Show Weakness Too?
finance.yahoo.com - November 30 at 5:55 PM
ENDRA Life Sciences to Present at the 10th Annual LD Micro Main Event on December 6, 2017ENDRA Life Sciences to Present at the 10th Annual LD Micro Main Event on December 6, 2017
finance.yahoo.com - November 23 at 6:47 AM
Should Your Next Investment In The Healthcare Industry Be In ENDRA Life Sciences Inc (NDRA)?Should Your Next Investment In The Healthcare Industry Be In ENDRA Life Sciences Inc (NDRA)?
finance.yahoo.com - November 18 at 7:08 AM
ENDRA Life Sciences Reports Third Quarter 2017 Financial ResultsENDRA Life Sciences Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 18 at 7:08 AM
ENDRA Life Sciences Contracts The Centre for Imaging Technology Commercialization (CIMTEC) to Initiate Human Studies with ENDRAs Clinical TAEUS(TM) Device Targeting Non-Alcoholic Fatty Liver DiseaseENDRA Life Sciences Contracts The Centre for Imaging Technology Commercialization (CIMTEC) to Initiate Human Studies with ENDRA's Clinical TAEUS(TM) Device Targeting Non-Alcoholic Fatty Liver Disease
finance.yahoo.com - November 9 at 7:31 AM
ENDRA Life Sciences Partners with StarFish Medical and CriTech Research to Commence Development of TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver DiseaseENDRA Life Sciences Partners with StarFish Medical and CriTech Research to Commence Development of TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease
finance.yahoo.com - November 4 at 7:44 AM
ENDRA Life Sciences to Host Third Quarter 2017 Results Conference Call on Wednesday, November 15, 2017 at 4:30 p.m. ETENDRA Life Sciences to Host Third Quarter 2017 Results Conference Call on Wednesday, November 15, 2017 at 4:30 p.m. ET
finance.yahoo.com - October 24 at 7:36 AM
ENDRA Life Sciences Completes Delivery and Installation of its Next Generation Nexus 128+ to Leading Research ... - Baystreet.caENDRA Life Sciences Completes Delivery and Installation of its Next Generation Nexus 128+ to Leading Research ... - Baystreet.ca
www.baystreet.ca - September 30 at 5:31 PM
This page was last updated on 11/13/2018 by MarketBeat.com Staff

Featured Article: Trading Strategy

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel